Put down the bag of chips: FDA issues Class I on Lays potato chips for undeclared allergen
According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Medscape3d
FDA OKs First-In-Class Nonopioid Pain Med Suzetrigine
Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...
Lay’s potato chip recall elevated to FDA’s highest-risk classification
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
FDA approves first new class of painkiller in 20 years, a non-addictive opioid alternative
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
Hosted on MSN3d
FDA approves 1st new class of opioid-free painkillers in over 20 years
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
Recall for broccoli sold at Walmart in 20 states upgraded to highest risk level: FDA
The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Lay’s potato chips recall upgraded to FDA’s most serious classification ahead of Super Bowl Sunday
With the big game on the horizon, many are planning their menus for Super Bowl Sunday. But if your shopping list contains Lay ...
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
‘Potentially deadly’: Chocolate recall upgraded to highest risk level in 9 American states | FDA
Multiple chocolate-covered products recalled in December due to mislabeled packaging and undeclared substances have been hit with FDA's Class 1 classification.
FDA approves new pain medicine as opioid alternative. What to know about Journavx
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...